Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
393,5 USD | +0,10% | -1,69% | -3,30% |
17/04 | VERTEX PHARMACEUTICALS INCORPORATED : UBS ribadisce il giudizio positivo sul titolo | ZM |
17/04 | VERTEX PHARMACEUTICALS INCORPORATED : Guggenheim ottimista sul caso | ZM |
Pubblicazioni ufficiali
SEC Filing 10K | CO | |
SEC Filing 13G | CO | |
SEC Filing 13G | CO | |
Slide show results | CO | |
Annual results | CO | |
SEC Filing 8K | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-3 | CO | |
Slide show Q3 | CO | |
3rd quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-2 | CO | |
Slide show half-year results | CO | |
1st-half-year results | CO | |
SEC Filing 8K | CO | |
SEC Filing 10Q-1 | CO | |
Slide show Q1 | CO | |
1st quarter results | CO | |
SEC Filing 8K | CO | |
SEC Filing 13G | CO | |
SEC Filing 10K | CO | |
SEC Filing 13G | CO | |
Slide show results | CO | |
Annual results | CO | |
SEC Filing 8K | CO |
- Borsa valori
- Azioni
- Azione VRTX
- Notizie Vertex Pharmaceuticals Incorporated
- Pubblicazioni ufficiali